Matthew Gillmor
Stock Analyst at Keybanc
(4.25)
# 336
Out of 4,827 analysts
46
Total ratings
51.61%
Success rate
17.82%
Average return
Main Sectors:
Stocks Rated by Matthew Gillmor
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EHC Encompass Health | Maintains: Overweight | $120 → $122 | $116.04 | +5.14% | 4 | Apr 25, 2025 | |
ACHC Acadia Healthcare Company | Maintains: Overweight | $70 → $65 | $22.81 | +184.96% | 3 | Mar 3, 2025 | |
HCA HCA Healthcare | Maintains: Overweight | $475 → $420 | $349.43 | +20.20% | 2 | Oct 28, 2024 | |
UNH UnitedHealth Group | Maintains: Overweight | $675 → $650 | $404.81 | +60.57% | 2 | Oct 16, 2024 | |
UHS Universal Health Services | Initiates: Sector Weight | n/a | $178.19 | - | 1 | Oct 11, 2024 | |
THC Tenet Healthcare | Initiates: Overweight | $200 | $148.77 | +34.44% | 1 | Oct 11, 2024 | |
SGRY Surgery Partners | Initiates: Sector Weight | n/a | $23.49 | - | 1 | Oct 11, 2024 | |
PRVA Privia Health Group | Initiates: Overweight | $23 | $22.96 | +0.17% | 1 | Oct 11, 2024 | |
INNV InnovAge Holding | Initiates: Sector Weight | n/a | $2.97 | - | 1 | Oct 11, 2024 | |
HUM Humana | Initiates: Sector Weight | n/a | $256.69 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $10.50 | +233.33% | 4 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $21.15 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $32.48 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $13.17 | +82.23% | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $15.48 | - | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $104.48 | +43.57% | 1 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $162 | $7.15 | +2,165.73% | 10 | May 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $28 | $25.24 | +10.94% | 3 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $16 | $12.93 | +23.74% | 2 | Apr 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.26 | - | 4 | Jun 14, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $64 | $66.37 | -3.57% | 1 | Sep 1, 2017 |
Encompass Health
Apr 25, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $116.04
Upside: +5.14%
Acadia Healthcare Company
Mar 3, 2025
Maintains: Overweight
Price Target: $70 → $65
Current: $22.81
Upside: +184.96%
HCA Healthcare
Oct 28, 2024
Maintains: Overweight
Price Target: $475 → $420
Current: $349.43
Upside: +20.20%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $675 → $650
Current: $404.81
Upside: +60.57%
Universal Health Services
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $178.19
Upside: -
Tenet Healthcare
Oct 11, 2024
Initiates: Overweight
Price Target: $200
Current: $148.77
Upside: +34.44%
Surgery Partners
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $23.49
Upside: -
Privia Health Group
Oct 11, 2024
Initiates: Overweight
Price Target: $23
Current: $22.96
Upside: +0.17%
InnovAge Holding
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $2.97
Upside: -
Humana
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $256.69
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $35
Current: $10.50
Upside: +233.33%
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $21.15
Upside: -
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $32.48
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $24
Current: $13.17
Upside: +82.23%
Oct 11, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $15.48
Upside: -
Oct 11, 2024
Initiates: Overweight
Price Target: $150
Current: $104.48
Upside: +43.57%
May 28, 2021
Initiates: Neutral
Price Target: $162
Current: $7.15
Upside: +2,165.73%
Apr 24, 2020
Maintains: Outperform
Price Target: $26 → $28
Current: $25.24
Upside: +10.94%
Apr 21, 2020
Maintains: Neutral
Price Target: $21 → $16
Current: $12.93
Upside: +23.74%
Jun 14, 2018
Downgrades: Neutral
Price Target: n/a
Current: $33.26
Upside: -
Sep 1, 2017
Initiates: Neutral
Price Target: $64
Current: $66.37
Upside: -3.57%